Clínica Universidad de Navarra (CUN)
Centro clínico de la Universidad de Navarra
Ikerbasque, Fundación Vasca para la Ciencia
Bilbao, EspañaPublications in collaboration with researchers from Ikerbasque, Fundación Vasca para la Ciencia (61)
2024
-
Epigenetic-based differentiation therapy for Acute Myeloid Leukemia
Nature Communications, Vol. 15, Núm. 1
2023
-
A second update on mapping the human genetic architecture of COVID-19
Nature
-
An engineered periosteum for efficient delivery of rhBMP-2 and mesenchymal progenitor cells during bone regeneration
npj Regenerative Medicine, Vol. 8, Núm. 1
-
Interactions between functional networks in Parkinson's disease mild cognitive impairment
Scientific Reports, Vol. 13, Núm. 1
2022
-
Cholangiocarcinoma landscape in Europe: Diagnostic, prognostic and therapeutic insights from the ENSCCA Registry
Journal of Hepatology, Vol. 76, Núm. 5, pp. 1109-1121
-
Multimodal brain and retinal imaging of dopaminergic degeneration in Parkinson disease
Nature Reviews Neurology, Vol. 18, Núm. 4, pp. 203-220
-
New molecular mechanisms in cholangiocarcinoma: signals triggering interleukin-6 production in tumor cells and KRAS co-opted epigenetic mediators driving metabolic reprogramming
Journal of Experimental and Clinical Cancer Research, Vol. 41, Núm. 1
-
The transcription factor DDIT3 is a potential driver of dyserythropoiesis in myelodysplastic syndromes
Nature Communications, Vol. 13, Núm. 1
2021
-
Correction: Current and novel therapeutic opportunities for systemic therapy in biliary cancer (British Journal of Cancer, (2020), 123, 7, (1047-1059), 10.1038/s41416-020-0987-3)
British Journal of Cancer
-
FOSL1 promotes cholangiocarcinoma via transcriptional effectors that could be therapeutically targeted
Journal of Hepatology, Vol. 75, Núm. 2, pp. 363-376
-
Functional correlates of response inhibition in impulse control disorders in Parkinson's disease
NeuroImage: Clinical, Vol. 32
-
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
Autophagy, Vol. 17, Núm. 1, pp. 1-382
-
O-GlcNAcylated p53 in the liver modulates hepatic glucose production
Nature Communications, Vol. 12, Núm. 1
-
The altered serum lipidome and its diagnostic potential for Non-Alcoholic Fatty Liver (NAFL)-associated hepatocellular carcinoma: Diagnosis of NAFLD-HCC utilising serum lipidomics
EBioMedicine, Vol. 73
2020
-
Abnormal pattern of brain glucose metabolism in Parkinson’s disease: replication in three European cohorts
European Journal of Nuclear Medicine and Molecular Imaging, Vol. 47, Núm. 2, pp. 437-450
-
Correction to: Motor impulsivity and delay intolerance are elicited in a dose-dependent manner with a dopaminergic agonist in parkinsonian rats (Psychopharmacology, (2020), 237, 8, (2419-2431), 10.1007/s00213-020-05544-6)
Psychopharmacology
-
Current and novel therapeutic opportunities for systemic therapy in biliary cancer
British Journal of Cancer, Vol. 123, Núm. 7, pp. 1047-1059
-
Disrupted salience network dynamics in Parkinson's disease patients with impulse control disorders
Parkinsonism and Related Disorders, Vol. 70, pp. 74-81
-
Dual pharmacological targeting of hdacs and pde5 inhibits liver disease progression in a mouse model of biliary inflammation and fibrosis
Cancers, Vol. 12, Núm. 12, pp. 1-27
-
Functional inhibitory control dynamics in impulse control disorders in Parkinson's disease
Movement Disorders, Vol. 35, Núm. 2, pp. 316-325